Physician profile
Amit Lahoti
NPI 1649219148
$254.63
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.69 · 2021: $17.50 · 2022: $74.06 · 2023: $28.38 · 2024: $47.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $75.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $75.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nxstage Medical, INC. | $74.06 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $71.82 | 2019-2024 | Jynarque |
| Vifor Pharma, INC. | $23.92 | 2019 | |
| Shire North American Group INC | $19.74 | 2019 | |
| Medtronic, INC. | $19.21 | 2024 | Intellis Adaptivestim |
| Sanofi-Aventis U.S. LLC | $17.50 | 2021 | |
| Endo Pharmaceuticals INC. | $15.28 | 2023 | Xiaflex, Aveed |
| Tactile Systems Technology INC | $13.10 | 2023 | Entre Plus, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Lahoti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.